CN106831994A - A kind of monoclonal antibody of S adenomethionine synthases and its application - Google Patents
A kind of monoclonal antibody of S adenomethionine synthases and its application Download PDFInfo
- Publication number
- CN106831994A CN106831994A CN201710154142.7A CN201710154142A CN106831994A CN 106831994 A CN106831994 A CN 106831994A CN 201710154142 A CN201710154142 A CN 201710154142A CN 106831994 A CN106831994 A CN 106831994A
- Authority
- CN
- China
- Prior art keywords
- monoclonal antibody
- seq
- amino acid
- sam
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/9116—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
- G01N2333/91165—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5) general (2.5.1)
- G01N2333/91171—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5) general (2.5.1) with definite EC number (2.5.1.-)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a kind of monoclonal antibody of S adenomethionine synthases, the weight chain variabl area sequence of described monoclonal antibody includes the amino acid sequence of the CDR2 shown in the amino acid sequence and SEQ ID NO.4 of the CDR1 shown in SEQ ID NO.2;With amino acid sequence of the light-chain variable sequence comprising the CDR3 shown in SEQ ID NO.6.With the polypeptide of the enzyme as immunogene, immune mouse obtains lymphocyte to the present invention, and fused cell is obtained using hybridoma cell fusion technology, obtains that high-affinity and high specific detection can be produced to set the cell line of the enzyme.The present invention can be used to detect S adenomethionine synthase contents in animal and plant body;The instrument that a targeting proteins are studied is provided with monoclonal antibody of the invention so that the deeper hierarchical research of protein expression change and albumen network collection of illustrative plates to different vegetation types, different lines or different development stage is achieved.
Description
Technical field
The invention belongs to monoclonal antibody biological technical field, more particularly to a kind of Dan Ke of SAM synzyme
Grand antibody and its application.
Background technology
SAM (SAM), English entitled S-adenosyl-methionine is in the life entities such as animal, plant
Important metabolic intermediate matter, is also a kind of important physiological activator in human body, and (scape is abundant, gland to participate in various biochemical reactions
Glycosides methionine, the chemistry of life, 1995,5:49), as participated in transmethylation in organism, turn aminopropyl effect and turn
Sulphur effect (LU S C, Regulation of hepatic glutathione synthesis Sem Liv Dis, 1998,
18:331-343).Prior art major part is studied it by starting with from the preparation method of SAM.
SAM be by substrate METHIONINE and ATP through S-adenosylmethionine synzyme enzyme' s catalysis, therefore, S- adenosines
Methionine synthetase is the key enzyme for synthesizing SAM, in the content of animals and plants vivo detection S-adenosylmethionine synzyme, can
Reflection influence animal and plant body synthesizes the factor of SAM, it can also be used to detect that different animal and plant bodies synthesize containing the S-adenosylmethionine
The analysis and research of enzyme.
At present on the market not specifically designed for the targeting antibodies of S-adenosylmethionine synzyme, therefore, in protein groups
In aspect, effective antibody instrument is lacked for the research field, for different vegetation types, different lines or different developments
Period the expression of enzymes ability level research.
The content of the invention
The present invention provides monoclonal antibody and its application of a kind of SAM synzyme, is deposited with solving prior art
Drawbacks described above, the present invention is by providing the instrument that targeting proteins are studied so as to different vegetation types, different lines
Or the protein expression change of different development stage and the deeper hierarchical research of albumen network collection of illustrative plates are achieved.
Technical scheme is as follows:
Present invention synthesis SAM synthesizes enzyme polypeptide, i.e., four group ' FTKCPEEIGA ' ' TDETPELMPL '
' QVTVEYYNDK ' and ' VLISTQHDET ', respectively using it as immunogene, immune mouse obtains lymphocyte, and using hybridization
Oncocyte integration technology is obtained fused cell, and through Western blot, limiting dilution assay and ELISA method, obtaining being capable of product parent high
With property and the cell line of the monoclonal antibody of high specific, and the monoclonal antibody secreted by the cell line, and through immune enzyme-linked,
Protein blot, co-immunoprecipitation adds the checking such as mass spectrum and antibody chip detection, determines most effective antibody.
A kind of monoclonal antibody of SAM synzyme, the weight chain variabl area sequence bag of described monoclonal antibody
The amino acid sequence of the CDR2 shown in the amino acid sequence and SEQ ID NO.4 of the CDR1 shown in the NO.2 of ID containing SEQ;And light chain
Amino acid sequence of the variable region sequences comprising the CDR3 shown in SEQ ID NO.6.
Preferably, the framework region of described weight chain variabl area sequence is successively comprising the amino acid shown in SEQ ID NO.1 and 3
Sequence, and described light-chain variable sequence framework region successively comprising the amino acid sequence shown in SEQ ID NO.5 and 7.
Monoclonal antibody the invention also discloses above-mentioned SAM synzyme is in detection SAM
Application on synzyme.
Preferably, the monoclonal antibody of SAM synzyme SAM synthesis in detection animal and plant body
The application of enzyme content.
Compared with prior art, beneficial effects of the present invention are as follows:
A kind of monoclonal antibody of SAM synzyme of the invention, has height to SAM synzyme
Affinity and high specific, can be widely used in the detection of SAM synzyme, being particularly useful for detecting animals and plants
Internal SAM synzyme content;Meanwhile, enzyme content, should by the expression of SAM in direct reaction body
Albumen mainly carries out biochemical reaction in liver, and is widely used in the treatment of the hepatopathys such as alcohol hepatopathy, liver lesion induced by drugs, should
Antibody will carry out the Cure of routine observation related liver disease patient as very effective detection means.Additionally, in protein group
Learn research field, monoclonal antibody of the invention provides the instrument of targeting proteins research so as to different vegetation types,
The protein expression change of different lines or different development stage and the deeper hierarchical research of albumen network collection of illustrative plates are achieved.
Brief description of the drawings
Fig. 1 is the intrinsic protein marking WB the results of cherry holoprotein lysate and clone's 2B7anti-SAM antibody
Schematic diagram;
Fig. 2 is the antibody chip detection of cherry holoprotein lysate and clone 2B7anti-SAM antibody and control antibodies
Result schematic diagram;
Fig. 3 is that clone 2B7anti-SAM antibody of the invention reacts with various concentrations SAM synzyme ELISA
Obtained standard curve.
Specific embodiment
With reference to specific embodiment, the present invention is expanded on further.It should be understood that these embodiments are merely to illustrate this hair
It is bright, rather than limit protection scope of the present invention.Those skilled in the art are according to changing that the present invention makes in actual applications
Enter and adjust, still fall within protection scope of the present invention.
The not special explanation of the present invention, technological means used is well known to those skilled in the art in following examples
Conventional technical means, and raw material, reagent used is also commercially available commercially available commodity.
A kind of preparation of the monoclonal antibody hybridoma cell of SAM synzyme of embodiment 1 and anti-S- adenosines egg
The preparation and purification of the monoclonal antibody of propylhomoserin synzyme
The preparation of 1.1 antigens
Synthesize four groups of SAMs synthesize enzyme polypeptide ' FTKCPEEIGA ' ' TDETPELMPL ' ' QVTVEYYNDK ' and
' VLISTQHDET ', and respectively using it as immunogene, aforementioned polypeptides also even-coupling VLP and tradition KLH systems it is immune
Originality enhancer.
1.2 immune mouses
Every group of antigen will be for being immunized 6 Balb/c mouse (8-12 week old), and it is optimal to determine to monitor its serum titer
Immune time.Each 6 immunogene polypeptide is mixed into one group.The adjuvant and immunization method for optimizing can be produced for most of anti-
The antibody (IgG hypotypes) of the high-affinity of former polypeptide.Mouse blood can will be taken after reinforcement by the reinforcement of 3 to 4 times after initial immunity
Clear detection titre (recombinant protein of SAM synzyme is used as anti-antigen coat).The qualified mouse of titre will impact one
Secondary and for merging, underproof mouse will continue one to strengthening twice, to titre highest after fusion.
1.3 Virus monitories and screening
Immune mouse eye socket takes blood, and detects that serum titer (make by the recombinant protein of SAM synzyme with ELISA
It is antigen coat).Serum titer need to be more than 10K, otherwise continue booster immunization.
1.4 fusions and screening
Full spleen and 1/2 lymph node are taken, is merged with myeloma SP2/0 cell lines.Technique is the PEG fusions for optimizing.Melt
Close cell and be taped against on 4 piece of 384 orifice plate (per hole cell 102 to 104), cultivated.The supernatant in all holes is collected, with ELISA pairs
Polypeptide detection original is screened, and the positive hole that microscopy has cell goes to 96 orifice plates and continues to cultivate.Growth after a few days, collects all holes
Supernatant detected with ELISA and solvable fragment detects former reaction.Further detect the solvable fragment of different dilution factors in positive hole
Detection is former to be combined, to carry out affinity sequence.20 Parental clones of each polypeptide immunogen affinity highest enter subclone.
60 Parental clones of each solvable fragment immunogen affinity highest enter subclone.
1.5 subclones and screening
Screened by limiting dilution assay and ELISA and be subcloned, obtain monoclonal hybridoma.Cell spreads 96 holes
Plate, and cultivate to the bottom of covering about 1/6.ELISA detects that each hole supernatant is former for the detection of solvable fragment and corresponding polypeptide is examined
Former reaction is surveyed, OD values height is taken and two good holes of cell state is subcloned into lower whorl.In steps be repeated alternatively until hole
Cell line positive rate 100%.Now we obtain monoclonal cell strain.After last wheel is subcloned, all positive cells
Amplification Culture immediately a, part freezes after being provided with and uses, and another part carries out supernatant or prepared by ascites.
1.6 antibody supernatants are prepared and purified
8 plants of monoclonal cell strains are finally obtained, and antibody producing is used for by abdomen injection to F1 mouse.The ascites of generation
Purified with Protein A/G, and for subsequent detection.
The checking of the anti-CK18 monoclonal antibodies of embodiment 2
8 plants of cell strain of monoclonal antibody to obtaining carry out immune enzyme-linked, and protein blot, co-immunoprecipitation adds mass spectrum, resists
The checking such as body chip, determines most effective antibody.
Elisa (immune enzyme-linked) pair verification of 2.1 antibody and antigen polypeptide
Take ascites antibody to be paired and be coated with 96 hole elisa plates, be incubated, skim milk is overnight closed after washing, PBS washings, 4
DEG C preservation is stand-by.Antigen polypeptide is incubated, PBS washings, while setting control.HRP marks detection antibody, and being added to incubation has foregoing
Elisa plate in.TMB chromogenic reactions, ELIASA reading.Screening obtains 8 potency of cell line as shown in Table 1:
Table one
The intrinsic protein marking (WB) checking of 2.2 antibody
Use cherry holoprotein lysate, antibody diluted concentration 1:1000、1:2000 and 1:5000 carry out WB checkings.Experiment
Result shows that anti-SAM (clone 2B7) can be consistent with specific identification 40KD bands in WB checkings with expected size,
As shown in Figure 1.
Co-immunoprecipitation (IP) plus the mass spectrum checking of 2.3 antibody
Cherry holoprotein 1mg is extracted, immunoprecipitation is carried out using anti-SAM (clone 2B7), it is big that IP products cut 40kd
Small band carries out Mass Spectrometer Method.As shown in Table 2, SAM is largely enriched with mass spectral results in IP samples, illustrates that this antibody is known to SAM
Other specificity is high, also, this antibody can apply to IP experiments.
Table two
2.4 antibody chip test experiences
Anti-SAM (clone 2B7) antibody and control antibodies point are formed on the glass with NC films as matrix using chip point sample instrument
Glass piece, forms the antibody point of a diameter of 100um.Apple holoprotein is carried out into biotin labeling, is incubated in by the concentration of 2ug/ml
On antibody chip, half an hour is incubated at room temperature.PBS softly cleaning three times, then be incubated with CY3-SA fluorescence secondary antibodies, PBS
Three times, chip is scanned using GenePix Fluorescence chip scanners 523nm.
Experimental result as shown in Fig. 2 Anti-SAM antibody has substantially enrichment to combine effect to target protein, fluorescence intensity compared with
By force, and not there is antigen-antibody binding reaction in control antibodies.
A kind of monoclonal antibody of SAM synzyme of the invention of embodiment 3 S- in detection different animals body
The application of adenomethionine synthase content
Because antibody of the invention has unique specificity to SAM synzyme, can be as special detection not
With the detection antibody of SAM synzyme content in animal and plant body, or this area also can be by according to conventional technical means
It is further developed as detection kit.
First, antibody of the present invention is with fixed concentration (1mg/ml) and various concentrations SAM synthetase recombinant protein
Standard items carry out ELISA experiments, obtain corresponding OD values, and draw out standard curve, abscissa is that SAM is closed
Into the concentration coordinate of enzyme, the OD value (OD values) that ordinate is measured for ELIASA, as shown in Figure 3.After the standard curve is used for
The continuous concentration that the OD values that sample to be tested is detected are converted into the enzyme;Wherein standard items are the restructuring egg of SAM synzyme
In vain, by BC A protein quantifications and examine dye and run glue and confirm concentration, and by 10ug/ml, 5ug/ml, 2.5ug/ml, 1.25ug/ml
Doubling dilution, as shown in Table 3.
Table three
Standard concentration (mg/ml) | 10 | 5 | 2.5 | 1.25 |
Standard items OD values | 2.856 | 2.154 | 1.521 | 0.857 |
Then, the tissue liquid sample for taking different peach classes carries out ELISA experiments, uses identical AC of the present invention
(1mg/ml) is detected, the OD values for obtaining substitute into standard curve and calculate, that is, obtain actual enzyme content in different animal and plant bodies
And corresponding expression, as shown in Table 4.
Table four
Detection OD values | Enzyme concentration conversion mg/ml | Expression | |
Honey peach | 1.869 | 1.88 | In |
Arabidopsis | 0.568 | 0.51 | It is low |
Zebra fish | 2.058 | 2.27 | In |
Serum | 3.254 | 7.52 | It is high |
Embodiment 4
Clone's 2B7anti-SAM antibody
The hybridoma cell strain of 2B7 clone's anti-SAM antibody is cultivated and extracted total serum IgE, by mRNA reverse transcriptions
Into the first chain cDNA;Heavy chain and light chain gene are expanded by PCR and amplification gene is cloned into sequencing vector, carry out multiple positives
Cloning and sequencing obtains ultimate sequence result.
Present invention disclosed above preferred embodiment is only intended to help and illustrates the present invention.Preferred embodiment is not detailed
All of details is described, it is only described specific embodiment that the invention is not limited yet.Obviously, according to the content of this specification,
Can make many modifications and variations.This specification is chosen and specifically describes these embodiments, is to preferably explain the present invention
Principle and practical application so that skilled artisan can be best understood by and utilize the present invention.The present invention is only
Limited by claims and its four corner and equivalent.
SEQUENCE LISTING
<110>Ai Bimate medical sci-teches(Shanghai)Co., Ltd
<120>A kind of monoclonal antibody of SAM synzyme and its application
<130>
<160> 7
<170> PatentIn version 3.5
<210> 1
<211> 24
<212> PRT
<213>Artificial sequence
<220>
<221> V_region
<222> (1)..(24)
<223> VHF1
<400> 1
Arg Gln Leu Gln Ile Thr Gly Ser Ser Leu Val Phe Pro Ala Gln Thr
1 5 10 15
Glu Ala Glu Thr Tyr Ser Val Gly
20
<210> 2
<211> 8
<212> PRT
<213>Artificial sequence
<220>
<221> V-region
<222> (1)..(8)
<223> VHCDR1
<400> 2
Val Phe Ile Ala Leu Thr Ala Pro
1 5
<210> 3
<211> 16
<212> PRT
<213>Artificial sequence
<220>
<221> V_region
<222> (1)..(16)
<223> VHF2
<400> 3
Asp Asn Gln Ile Thr Met Ile Pro Met Leu Ser Leu Glu Tyr Arg Asn
1 5 10 15
<210> 4
<211> 7
<212> PRT
<213>Artificial sequence
<220>
<221> V_region
<222> (1)..(7)
<223> VHCDR2
<400> 4
Tyr Ser Gln Leu Leu Ala Thr
1 5
<210> 5
<211> 35
<212> PRT
<213>Artificial sequence
<220>
<221> V_region
<222> (1)..(35)
<223> VLF3
<400> 5
Pro Arg Phe Pro Val Ile Ile Gln Arg Leu Gly Pro Val Phe Gly Asp
1 5 10 15
Val Phe Thr Leu Thr Val Ile Met Met Gln Glu Gln Arg Leu Ser Asp
20 25 30
Tyr Glu Thr
35
<210> 6
<211> 10
<212> PRT
<213>Artificial sequence
<220>
<221> V_region
<222> (1)..(10)
<223> VLCDR3
<400> 6
Tyr Gln Ser Thr Ile Ser Pro Glu Arg Val
1 5 10
<210> 7
<211> 10
<212> PRT
<213>Artificial sequence
<220>
<221> V_region
<222> (1)..(10)
<223> VLF4
<400> 7
Gly Gly Ser Glu Gly Lys Val Glu Lys Thr
1 5 10
Claims (4)
1. a kind of monoclonal antibody of SAM synzyme, it is characterised in that the heavy chain of described monoclonal antibody can
The amino acid of the CDR2 shown in amino acid sequence of the change region sequence comprising the CDR1 shown in SEQ ID NO.2 and SEQ ID NO.4
Sequence;With amino acid sequence of the light-chain variable sequence comprising the CDR3 shown in SEQ ID NO.6.
2. the monoclonal antibody of SAM synzyme according to claim 1, it is characterised in that described heavy chain
The framework region of variable region sequences is successively comprising the amino acid sequence shown in SEQ ID NO.1 and 3, and described light chain variable district sequence
The framework region of row is successively comprising the amino acid sequence shown in SEQ ID NO.5 and 7.
3. the monoclonal antibody of the SAM synzyme described in claim 1 is on detection SAM synzyme
Application.
4. the monoclonal antibody of SAM synzyme according to claim 3 is detecting S- adenosines in animal and plant body
The application of methionine synthase content.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710154142.7A CN106831994A (en) | 2017-03-15 | 2017-03-15 | A kind of monoclonal antibody of S adenomethionine synthases and its application |
CN201710509182.9A CN107383199B (en) | 2017-03-15 | 2017-06-28 | Monoclonal antibody of S-adenosylmethionine synthetase and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710154142.7A CN106831994A (en) | 2017-03-15 | 2017-03-15 | A kind of monoclonal antibody of S adenomethionine synthases and its application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106831994A true CN106831994A (en) | 2017-06-13 |
Family
ID=59145122
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710154142.7A Withdrawn CN106831994A (en) | 2017-03-15 | 2017-03-15 | A kind of monoclonal antibody of S adenomethionine synthases and its application |
CN201710509182.9A Active CN107383199B (en) | 2017-03-15 | 2017-06-28 | Monoclonal antibody of S-adenosylmethionine synthetase and application thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710509182.9A Active CN107383199B (en) | 2017-03-15 | 2017-06-28 | Monoclonal antibody of S-adenosylmethionine synthetase and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN106831994A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112094346B (en) * | 2020-06-01 | 2024-01-05 | 普众发现医药科技(上海)有限公司 | Monoclonal antibody of mouse anti-cell single-chain transmembrane glycoprotein CD142 capable of being applied to tumor cell capture |
CN112279917B (en) * | 2020-06-01 | 2024-01-05 | 普众发现医药科技(上海)有限公司 | Monoclonal antibody of mouse anti-cell surface glycoprotein CD138 capable of being applied to tumor cell capture |
CN112094350B (en) * | 2020-06-01 | 2024-01-05 | 普众发现医药科技(上海)有限公司 | Monoclonal antibody of mouse anti-cell surface glycoprotein CD326 applicable to tumor cell capture |
CN112094345B (en) * | 2020-06-01 | 2024-01-05 | 普众发现医药科技(上海)有限公司 | Mouse anti-immunoglobulin associated beta CD79b monoclonal antibody applicable to tumor cell capture |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5686255A (en) * | 1995-05-24 | 1997-11-11 | Deth; Richard C. | Compositions and methods for diagnosing schizophrenia |
US6313265B1 (en) * | 1995-07-24 | 2001-11-06 | The Scripps Research Institute | Neurite outgrowth-promoting polypeptides containing fibronectin type III repeats and methods of use |
US7045612B2 (en) * | 1998-01-16 | 2006-05-16 | Mcgill University | Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, and cancer |
CN1307103A (en) * | 2000-01-21 | 2001-08-08 | 上海博道基因技术有限公司 | Polypeptide-S-adenosylmethionine synthetase 31 and polynucleotide for coding said polypeptide |
-
2017
- 2017-03-15 CN CN201710154142.7A patent/CN106831994A/en not_active Withdrawn
- 2017-06-28 CN CN201710509182.9A patent/CN107383199B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN107383199A (en) | 2017-11-24 |
CN107383199B (en) | 2020-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1771338B (en) | High affinity anti-human IgE antibodies | |
CN106831994A (en) | A kind of monoclonal antibody of S adenomethionine synthases and its application | |
CN106699891A (en) | Anti-PD-L1 antibody as well as pharmaceutical composition and application of anti-PD-L1 antibody | |
ZA200106809B (en) | Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases. | |
CN116769023B (en) | Mouse anti-marneffei basket mannoprotein hybridoma cell strain, monoclonal antibody and application | |
CN109406771A (en) | Cystatin C latex-enhanced turbidimetry detection kit and its preparation application method | |
CN114478784B (en) | ENO2 monoclonal antibody 1C5, and preparation method and application thereof | |
CN109734803A (en) | Anti-human MYO antibody and its application in detection kit | |
CN106866820A (en) | A kind of monoclonal antibody and its application for capturing the anti-human Keratin 18 of tumour cell | |
CN104479022B (en) | Anti- S adenosyl homocysteines monoclonal antibody 301, its hybridoma, composition, colloid gold test paper, kit and purposes | |
CN107266576A (en) | A kind of monoclonal antibody of carboxylic oxidase of 1 amino-cyclopropane 1 and its application | |
CN109535255A (en) | A kind of anti-human CD26 antibody and its application in detection kit | |
CN108456252B (en) | The anti-rabbit IgG native conformation monoclonal antibody of high specific | |
CN109336973A (en) | Antitransferrin antibody and application thereof | |
CN108318695A (en) | People RBP colloidal gold immunochromatographimethod quantitative testing test paper cards and its clinical application | |
CN114213541A (en) | Monoclonal antibody of totipotent nuclease and preparation method thereof | |
CN110540966B (en) | Human haemophilus influenzae surface protein monoclonal antibody and antigen capture ELISA kit | |
EP1765867B1 (en) | Monoclonal antibodies to hiv-1 vpr and methods of using same | |
CN110317271A (en) | Weight/the light chain variable region and encoding gene and recombinant antibodies of a kind of PINP recombinant antibodies | |
EP2187216B1 (en) | Novel liver cancer marker | |
CN114478783B (en) | ENO2 monoclonal antibody, and preparation method and application thereof | |
CN112094345B (en) | Mouse anti-immunoglobulin associated beta CD79b monoclonal antibody applicable to tumor cell capture | |
Galkin et al. | New monoclonal antibodies to the Chlamydia trachomatis main outer membrane protein and their immunobiological properties | |
CN114262378B (en) | OMT monoclonal antibody and preparation method thereof | |
CN108484770A (en) | Recombinant rat anti-mouse CD4 monoclonal antibodies, preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170613 |
|
WW01 | Invention patent application withdrawn after publication |